Regulatory decisions pertaining to aprotinin may be putting patients at risk.Published in:Canadian Medical Association Journal (CMAJ), 2014, v. 186, n. 18, p. 1379, doi. 10.1503/cmaj.131582By:Hébert, Paul C.;Fergusson, Dean A.;Hutton, Brian;Mazer, C. David;Fremes, Stephen;Blajchman, Morris;MacAdams, Charles;Wells, George;Robblee, Jim;Bussieres, Jean;Teoh, KevinPublication type:Article